The effects of single dose oral hydralazine on blood flow through human lung tumours

This publication has 35 references indexed in Scilit:

• Murine tumor and normal tissue blood flow measured by laser doppler flowmetry: Effect of nicotinamide, flunarizine and hydralazine
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine : effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069
  Radiotherapy and Oncology, 1989
• Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugs
  International Journal of Radiation Oncology*Biology*Physics, 1989
• The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Quantitative SPECT imaging
  Nuclear Medicine Communications, 1986
• Tumor Blood Flow-Characterization, Modifications, and Role in Hyperthermia
  IEEE Transactions on Sonics and Ultrasonics, 1984
• Abnormal Response of Tumor Vasculature to Vasoactive Drugs23
  JNCI Journal of the National Cancer Institute, 1984
• Theoretical feasibility of vasodilator-enhanced local tumor heating
  European Journal of Cancer and Clinical Oncology, 1982
• A Method for Attenuation Correction in Radionuclide Computed Tomography
  IEEE Transactions on Nuclear Science, 1978
• Effects of vasomotor drugs and “mediators” of the inflammatory reaction upon the oxygen tension of tumours and tumour blood-flow.
  British Journal of Cancer, 1966